Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · IEX Real-Time Price · USD
29.24
+0.12 (0.41%)
At close: Mar 28, 2024, 4:00 PM
29.02
-0.22 (-0.75%)
After-hours: Mar 28, 2024, 4:05 PM EDT

Agios Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Cash & Equivalents
88.21139.26203.13127.4480.9370.5102.72160.7571.7614.03
Upgrade
Short-Term Investments
688.72643.86816.89445.49483.95514.8321.21380.56245.24328.03
Upgrade
Cash & Cash Equivalents
776.93783.121,020572.93564.88585.3423.94541.31317342.07
Upgrade
Cash Growth
-0.79%-23.22%78.04%1.43%-3.49%38.06%-21.68%70.76%-7.33%104.41%
Upgrade
Receivables
2.812.214.38015.3210.443.678.3111.68.83
Upgrade
Inventory
19.088.49007.330.870000
Upgrade
Other Current Assets
35.0238.9639.8463.7524.1817.1717.6610.268.738.66
Upgrade
Total Current Assets
833.84832.771,064636.68611.7613.78445.26559.89337.33359.55
Upgrade
Property, Plant & Equipment
69.7988.12104.23116.07126.1124.3224.4325.3423.226.39
Upgrade
Long-Term Investments
29.44313.87266.3897.61152.93220.12143.8132.2558.91125.38
Upgrade
Other Long-Term Assets
4.063.962.92.600.240.891.620.610.59
Upgrade
Total Long-Term Assets
103.28405.95373.51216.28279.04244.68169.1459.282.74132.36
Upgrade
Total Assets
937.121,2391,438852.95890.74858.46614.4619.09420.07491.9
Upgrade
Accounts Payable
9.7818.6216.717.7221.917.8822.7717.1114.7511.07
Upgrade
Deferred Revenue
000061.5192.52163.64190.2124.3638.41
Upgrade
Current Debt
15.0113.6611.167.416.9200000
Upgrade
Other Current Liabilities
43.1730.3531.9769.262.56-16.9-91.47-118.8813.7811.61
Upgrade
Total Current Liabilities
67.9662.6359.8394.3992.8993.594.9488.4352.8961.09
Upgrade
Long-Term Debt
56.997285.9497.79106.7500000
Upgrade
Other Long-Term Liabilities
1.163.280261.2750.5877.42143.95172.0722.066.45
Upgrade
Total Long-Term Liabilities
58.1475.2885.94359.06157.3377.42143.95172.0722.066.45
Upgrade
Total Liabilities
126.1137.9145.76453.45250.21170.92238.89260.574.9567.54
Upgrade
Total Debt
7285.6697.09105.2113.6600000
Upgrade
Debt Growth
-15.95%-11.78%-7.70%-7.45%------
Upgrade
Retained Earnings
-822.65-470.56-238.76-1,843.48-1,516.11-1,104.63-798.06-483.15-284.68-166.95
Upgrade
Comprehensive Income
-0.44-12.54-1.20.110.2-2.17-1.39-0.31-0.32-0.06
Upgrade
Shareholders' Equity
811.021,1011,292399.5640.53687.54375.5358.59345.12424.37
Upgrade
Net Cash / Debt
704.93697.46922.92467.73451.22585.3423.94541.31317342.07
Upgrade
Net Cash / Debt Growth
1.07%-24.43%97.32%3.66%-22.91%38.06%-21.68%70.76%-7.33%104.41%
Upgrade
Net Cash Per Share
12.6712.7315.276.787.5210.199.1013.848.4710.16
Upgrade
Working Capital
765.88770.141,004542.28518.82520.28350.32471.46284.44298.46
Upgrade
Book Value Per Share
14.5720.0921.375.7910.6811.978.069.169.2212.61
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).